These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 29900762

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pituitary pars intermedia dysfunction (Equine Cushing's disease) in an onager (Equus hemionus onager).
    Peel AJ, Bouts T, Flach E, Rivers S, Routh A.
    J Zoo Wildl Med; 2009 Dec; 40(4):773-80. PubMed ID: 20063825
    [Abstract] [Full Text] [Related]

  • 3. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
    Menzies-Gow NJ, Banse HE, Duff A, Hart N, Ireland JL, Knowles EJ, McFarlane D, Rendle D.
    Equine Vet J; 2024 Mar; 56(2):220-242. PubMed ID: 37795557
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pituitary pars intermedia dysfunction: equine Cushing's disease.
    Schott HC.
    Vet Clin North Am Equine Pract; 2002 Aug; 18(2):237-70. PubMed ID: 15635907
    [Abstract] [Full Text] [Related]

  • 6. Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence.
    Carmalt JL, Waldner CL, Allen AL.
    Can J Vet Res; 2017 Oct; 81(4):261-269. PubMed ID: 29081583
    [Abstract] [Full Text] [Related]

  • 7. Uterine adenocarcinoma in a Przewalski's wild horse (Equus ferus przewalskii).
    Thompson R, Armién AG, Rasmussen JM, Wolf TM.
    J Zoo Wildl Med; 2014 Jun; 45(2):441-5. PubMed ID: 25000717
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses.
    McGowan TW, Pinchbeck GP, McGowan CM.
    Equine Vet J; 2013 Jan; 45(1):74-9. PubMed ID: 22594955
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suspensory ligament degeneration associated with pituitary pars intermedia dysfunction in horses.
    Hofberger S, Gauff F, Licka T.
    Vet J; 2015 Mar; 203(3):348-50. PubMed ID: 25641552
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lumbar vertebral bone density is decreased in horses with pituitary pars intermedia dysfunction.
    Colbath AC, Fortin JS, Burglass CM, Panek C, Vergara-Hernandez FB, Johnson TN, Robison CA, Logan AA, Nelson NA, Nielsen BD, Schott HC.
    Equine Vet J; 2024 Mar; 56(2):368-376. PubMed ID: 38151767
    [Abstract] [Full Text] [Related]

  • 19. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction.
    McFarlane D, Dybdal N, Donaldson MT, Miller L, Cribb AE.
    J Neuroendocrinol; 2005 Feb; 17(2):73-80. PubMed ID: 15796757
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.